使用深潜变量路径建模整合多模式癌症数据
Alex Ing1, Alvaro Andrades1, Marco Raffaele Cosenza1
1Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Nature machine intelligence
|July 25, 2025
概括
我们开发了深度潜伏变量路径建模,以整合复杂的癌症数据,优于传统方法. 这种方法通过揭示不同数据类型之间的关联来增强对癌症病理学的理解.
科学领域:
- 计算生物学是一种计算生物学.
- 生物信息学是一种生物信息学.
- 癌症研究 癌症研究
背景情况:
- 癌症病理学是复杂的,涉及遗传,显微和宏观特征.
- 整合各种数据类型 (成像,奥米克) 以全面了解癌症仍然是一个挑战.
研究的目的:
- 在癌症研究中引入深潜变量路径建模 (DLVP) 以集成多omics和组织学数据.
- 展示DLVP在癌症病理学中绘制复杂关系的能力.
主要方法:
- 开发了DLVP,将深度学习和路径建模结合起来,以识别复杂系统中的相互依赖.
- 在癌症基因组图谱 (TCGA) 乳腺癌数据上接受过DLVP培训,包括单核酸变异,甲基化,微RNA,RNA测序和组织学.
- 应用DLVP来分层单细胞数据,识别合成致命相互作用,并检测组织学-转录协会.
主要成果:
- 与经典路径建模相比,DLVP在不同数据类型之间绘制关联方面表现优越.
- 成功应用DLVP分析单细胞,CRISPR-Cas9屏幕和空间转录基因数据.
- 该模型提供了一个统一的框架来解释来自各种数据模式的结果.
结论:
- DLVP提供了一种强大的新方法,用于综合分析多模式癌症数据.
- 这种方法有助于更全面地了解癌症病理和疾病机制.
- 在各种癌症研究数据类型和应用中,DLVP具有广泛的适用性.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.5K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
01:21Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
127
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
127
01:14Multicompartment Models: Overview
258
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
258
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K